Companies / DarioHealth Corp.

DarioHealth Corp.

Nasdaq: DRIOCIK 1533998NEW YORK, NY

Financials · FY2018

Revenue$7.39M
Net income$-41.71M
Total debt$39.65M
Cash$6.63M
Diluted EPS$10.12
Shares outstanding9.8M

Ownership

9.8M shares outstanding · as of Aug 11, 2026
7.8%Institutions
Ownership
Institutions7.83%766,960
Public float92.17%9,032,521

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares

Institutional holders 17

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon Stock$125.3K+19K
+100.85%
37,796
0.39% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$98.8K+12K
+24.84%
61,878
0.63% of shares
low
Q1 2026
as of
Royal Bank of Canada
13F manager
AddCommon Stock$2.1K+319
+247.29%
448
<0.01% of shares
low
Q4 2025
as of
Bank of America Corp /De
13F manager
AddCommon Stock$353+31
+119.23%
57
<0.01% of shares
low
Q1 2026
as of
Whittier Trust Co
13F manager
ExitCommon Stock$-202-15
-100.00%
0
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Nantahala Capital Management, LLCPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DRIOCommon StockEquity23725P308BBG003V5P7K2